Assignee
CAMH
CA29 patents
Top patents by PatentIndex Score
US7670773B2Mar 2, 2010
MECP2E1 gene
CAMH10 citations83
US10828343B2Nov 10, 2020
Methods, compositions, and kits addressing depressed mood
CAMH2 citations66
US10478467B2Nov 19, 2019
Methods and compositions addressing depressed mood
CAMH2 citations66
US10034852B2Jul 31, 2018
Methods and compositions addressing depressed mood
CAMH5 citations66
US6749830B2Jun 15, 2004
Method for the synthesis of radiolabeled compounds
CAMH8 citations62
US10435748B2Oct 8, 2019
Genetic markers associated with suicide risk and methods of use thereof
CAMH1 citations58
US11684647B2Jun 27, 2023
Methods, compositions, and kits addressing depressed mood
CAMH0 citations56
US6998235B2Feb 14, 2006
Method of determining susceptibility to bipolar disorders
CAMH3 citations55
US7794934B2Sep 14, 2010
Predicting negative symptom change during drug treatment
CAMH3 citations54
US7101666B2Sep 5, 2006
Involvement of the BDNF gene in mood disorders
CAMH3 citations53
US9518104B2Dec 13, 2016
Compositions and methods for treating multiple sclerosis
CAMH0 citations52
US8552152B2Oct 8, 2013
Compositions and methods for modulating dopamine neurotransmission
CAMH0 citations52
US9708385B2Jul 18, 2017
Nucleic acids encoding polypeptides which disrupt D1-D2 dopamine receptor coupling and modulate function
CAMH0 citations51
US9670544B2Jun 6, 2017
CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
CAMH0 citations51
US9266954B2Feb 23, 2016
Methods for modulating D1-D2 dopamine receptor coupling and function
CAMH0 citations51
US9096903B2Aug 4, 2015
CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
CAMH0 citations51
US11104952B2Aug 31, 2021
Genetic markers for suicide risk and related methods
CAMH0 citations47
US12230384B2Feb 18, 2025
Medical tool aiding diagnosed psychosis patients in detecting auditory psychosis symptoms associated with psychosis
CAMH0 citations46
US11763929B2Sep 19, 2023
Medical tool aiding diagnosed psychosis patients in detecting auditory psychosis symptoms associated with psychosis
CAMH0 citations46
US9617320B2Apr 11, 2017
Nucleic acids encoding FHL1 mutations associated with novel X-linked muscular myopathies and methods of screening a subject
CAMH0 citations44
US9150923B2Oct 6, 2015
Methods of identifying FHL1 mutations associated with novel X-linked muscular myopathies
CAMH0 citations44
US7666597B2Feb 23, 2010
Marker for tardive dyskinesia
CAMH0 citations43
US7122308B2Oct 17, 2006
Detection of antidepressant induced mania
CAMH1 citations42
US12398139B2Aug 26, 2025
Modulators of AMPA receptor signaling
CAMH0 citations40
US10301678B2May 28, 2019
Genetic markers for antipsychotic induced weight gain and methods for use thereof
CAMH0 citations36
US7368264B2May 6, 2008
SLC1A1 marker for anxiety disorder
CAMH1 citations36
US10745736B2Aug 18, 2020
Markers for mood disorders
CAMH0 citations34
US10302625B2May 28, 2019
Peripheral measure of central brain inflammation, markers therefor and uses thereof
CAMH0 citations32
US10662475B2May 26, 2020
Compositions and methods for the treatment and prevention of antipsychotic medication-induced weight gain
CAMH0 citations27